Survodutide for Sale | 3rd-Party Tested Pure | Purerawz Metabolic Research Peptide
What is Survodutide?
Survodutide, also identified by its research designation BI456906, is a synthetic peptide-based dual agonist developed by Boehringer Ingelheim. What makes Survodutide scientifically distinctive is its ability to simultaneously target two separate metabolic hormone receptors: the glucagon-like peptide-1 receptor (GLP-1R) and the glucagon receptor (GCGR). This dual receptor targeting approach has positioned Survodutide as a compound of significant interest for researchers studying metabolic dysfunction-associated steatohepatitis (MASH), obesity, and related metabolic disorders in preclinical and clinical research models.
As one of the more clinically advanced synthetic peptide research compounds currently under investigation, Survodutide has progressed to Phase 3 clinical trial evaluation, making it a particularly relevant research tool for scientists working at the frontier of metabolic disease investigation.
All peptides on Purerawzus.com are strictly intended for laboratory and research use only and are not approved by the FDA for human or veterinary use.
Survodutide Chemical Properties
|
Property |
Details |
|
Product Name |
Survodutide |
|
Synonyms |
BI456906, GTPL13383, EX-A7878 |
|
CAS Number |
2805997-46-8 |
|
PubChem CID |
168429725 |
|
Molecular Formula |
C192H289N47O61 |
|
Molecular Weight |
4232 g/mol |
|
Solubility |
PBS (pH 7.2): Soluble at greater than or equal to 10 mg/ml |
|
Long-Term Storage |
-80°C powder, -80°C solvent for up to 6 months |
|
Short-Term Storage |
-20°C powder and solvent |
|
Research Use |
Laboratory and Scientific Research Only |
|
Regulatory Status |
Not approved by the FDA for human or veterinary use |
How Does Survodutide Work?
The scientific value of Survodutide lies in its dual receptor mechanism. By activating both GLP-1R and GCGR simultaneously researchers can study how combined metabolic hormone receptor signaling influences multiple interconnected biological pathways. Each receptor activation produces distinct and complementary research outcomes in preclinical models:
GLP-1 Receptor Activation
When Survodutide binds to GLP-1 receptors located in the brain and pancreas it may trigger several metabolic signaling responses in research models:
|
GLP-1R Mechanism |
Research Context |
|
Appetite and Food Intake Reduction |
May reduce appetite and total food intake in preclinical research models |
|
Gastric Emptying Modulation |
May slow the rate of gastric emptying in experimental settings |
|
Glucose-Dependent Insulin Secretion |
May enhance insulin secretion in a glucose-dependent manner in research models |
Glucagon Receptor Activation
GCGR activation through Survodutide primarily occurs in liver tissue of preclinical models and may produce the following research-relevant effects:
|
GCGR Mechanism |
Research Context |
|
Energy Expenditure Increase |
May contribute to increased energy expenditure in metabolic research models |
|
Lipolysis and Fat Oxidation |
May promote fat breakdown and oxidation in preclinical research settings |
|
Hepatic Fat Reduction |
May help reduce fat accumulation in liver tissue in experimental models |
Potential Benefits of Survodutide in Research
Scientific investigation into Survodutide has highlighted several areas where this dual agonist may offer significant research value across metabolic and liver disease research disciplines:
|
Potential Benefit |
Research Context |
|
MASH Research |
Being investigated for its possible role in metabolic dysfunction-associated steatohepatitis |
|
Obesity Research |
Studied for its possible applications in weight management and obesity mechanism research |
|
Type 2 Diabetes Research |
Being explored for its possible role in glucose regulation and insulin sensitivity research |
|
Fatty Liver Research |
Studied for its possible effects on hepatic fat accumulation reduction in research models |
|
Appetite Suppression Research |
Being investigated for its possible role in appetite regulation mechanisms |
|
Cardiovascular Research |
Being evaluated for possible cardiovascular and metabolic outcome research in preclinical models |
|
Lipid Metabolism Research |
Studied for its possible influence on lipolysis and fat oxidation in research settings |
|
Body Composition Research |
Being explored for its possible effects on body composition in metabolic research models |
Please note: All benefits listed are based on preclinical and early clinical research. This product is strictly intended for research purposes and is not approved for human or veterinary use.
Potential Research Areas of Survodutide
|
Research Area |
Potential Focus |
|
MASH and NAFLD Research |
Studying its possible role in metabolic dysfunction-associated liver disease research |
|
Obesity and Weight Management Research |
Investigating appetite suppression and weight regulation mechanisms in research models |
|
Type 2 Diabetes Research |
Exploring its possible role in glucose regulation and insulin sensitivity in diabetic models |
|
GLP-1 Receptor Research |
Studying GLP-1R activation and its downstream metabolic signaling effects |
|
Glucagon Receptor Research |
Investigating GCGR activation and its role in hepatic fat and energy metabolism |
|
Dual Agonist Research |
Studying how simultaneous GLP-1R and GCGR activation influences metabolic outcomes |
|
Cardiovascular Metabolic Research |
Exploring possible cardiovascular outcomes associated with dual receptor metabolic signaling |
|
Gastrointestinal Research |
Investigating its possible effects on gastric emptying and gastrointestinal motility |
|
Hepatic Fat Research |
Studying its possible role in reducing liver fat accumulation in preclinical models |
|
Energy Expenditure Research |
Investigating its possible influence on total energy expenditure in metabolic research |
Handling and Storage of Survodutide
Proper handling and storage of Survodutide are essential for maintaining compound integrity throughout all research applications:
|
Condition |
Recommendation |
|
Long-Term Powder Storage |
Store at -80°C for extended preservation |
|
Short-Term Powder Storage |
Store at -20°C for shorter research periods |
|
Solvent Storage |
Store at -80°C for up to 6 months or -20°C for shorter durations |
|
Container Management |
Keep vials tightly sealed and clearly labelled with concentration and reconstitution date |
|
Contamination Prevention |
Use sterile containers at all times |
|
Moisture Control |
Keep away from moisture and humidity throughout storage |
|
Transportation |
Check all airport and customs regulations before traveling with Survodutide |
|
Environmental Safety |
Do not allow entry into sewers, surface water, or groundwater |
|
Inhalation Prevention |
Avoid inhalation and contact with eyes and skin during handling |
|
Ventilation |
Use only in areas with appropriate exhaust ventilation |
|
Expiration Compliance |
Do not use after the expiration date shown on packaging |
Why Buy Survodutide from Purerawzus.com?
Pure raws is your trusted source for research-grade Survodutide. Available in capsule, nasal spray, and powder formats, we offer researchers the flexibility to select the most appropriate form for their specific study requirements. Every product is first and third-party tested and comes with a full Certificate of Analysis confirming identity, purity, and concentration. Visit our how to pay page for a complete step by step guide to all available payment methods and secure checkout instructions.
|
Feature |
Details |
|
Available Forms |
Capsule, Nasal Spray, Powder |
|
Testing |
First and independent third-party lab tested |
|
Documentation |
Certificate of Analysis (COA) included with every order |
|
Shipping |
Free international shipping on orders over $100 |
|
Payment Options |
Multiple secure payment methods available |
|
Support |
24/7 expert customer support |
Frequently Asked Questions
Is Survodutide Safe for Human Consumption?
No. The FDA has not approved Survodutide for human or veterinary use. Purerawzus.com supplies this compound strictly for laboratory and scientific research purposes only.
What Side Effects Have Been Observed With Survodutide?
As Survodutide remains under active clinical and preclinical investigation its complete side effect profile has not yet been fully established in all research contexts. Researchers are encouraged to follow all applicable laboratory safety protocols when handling this compound.
How Should Survodutide be Stored?
Store Survodutide powder at -80°C for long-term preservation or at -20°C for shorter storage periods. For solvent storage maintain at -80°C for up to six months or at -20°C for shorter durations. Keep vials tightly sealed and labelled and store in sterile containers away from moisture and humidity at all times.
Is Survodutide Legal for Research Use?
Survodutide is legal for laboratory and research use in applicable regions. The FDA has not approved it for human or veterinary applications. All research must comply with applicable institutional standards and local regulatory guidelines before purchasing or using this compound.
Disclaimer
All information on this page is provided for educational purposes only and does not constitute medical or professional advice. Products are for laboratory and research use only. By ordering you agree to our Terms and Conditions. Contact us at sales@purerawzus.com for any concerns.
All products are for laboratory and research purposes only and are not intended for veterinary or human use.
References
le Roux, C. W., Wharton, S., Bozkurt, B., Platz, E., Bleckert, G., Ajaz Hussain, S., Brueckmann, M., Startseva, E., Kloer, I. M., & Kaplan, L. M. (2025). Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE-1). Diabetes, Obesity, and Metabolism.




Reviews
There are no reviews yet.